Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.31 --0%
EPS Growth %: +50.0%
Financial Fact:
Total cost of sales: 77.87K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +50.0%
Financial Fact:
Total cost of sales: 77.87K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02).
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Former Fed Chair Alan Greenspan dies at 100
- Eledon Pharamceuticals (ELDN) Reiterated at Overweight by Cantor Fitzgerald
- BitGo Holdings (BTGO) Reiterated at Overweight by Cantor Fitzgerald on Share Repurchase Plan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
